AI-Based Deviation and CAPA Workflows: Validation Challenges
AI-Based Deviation and CAPA Workflows: Validation Challenges Addressing Validation Challenges in AI-Based Deviation and CAPA Workflows Pharmaceutical manufacturers increasingly leverage advanced GMP automation solutions incorporating artificial intelligence (AI) to optimize Deviation and Corrective and Preventive Action (CAPA) processes. These innovations promise enhanced efficiency, improved data integrity, and faster root cause analysis. However, integrating AI modules…
Read More “AI-Based Deviation and CAPA Workflows: Validation Challenges” »